Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/13643
Title: P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death.
Authors: Johnstone, R W;Cretney, E;Smyth, Mark J
Affiliation: The Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia. r.johnstone@ari.unimelb.edu.au
Issue Date: 1-Feb-1999
Citation: Blood; 93(3): 1075-85
Abstract: A major problem with treating patients with cancer by traditional chemotherapeutic regimes is that their tumors often develop a multidrug resistant (MDR) phenotype and subsequently become insensitive to a range of different chemotoxic drugs. One cause of MDR is overexpression of the drug-effluxing protein, P-glycoprotein. It is now apparent that P-glycoprotein may also possess a more generic antiapoptotic function that protects P-glycoprotein-expressing cancer cells and normal cells from cell death. Herein we show that cells induced to express P-glycoprotein either by drug selection or by retroviral gene transduction with MDR1 cDNA are resistant to cell death induced by a wide range of death stimuli, such as FasL, tumor necrosis factor (TNF), and ultraviolet (UV) irradiation, that activate the caspase apoptotic cascade.However, P-glycoprotein-expressing cells were not resistant to caspase-independent cell death mediated by pore-forming proteins and granzyme B.MDR P-glycoprotein-expressing cells were made sensitive to caspase-dependent apoptosis by the addition of anti-P-glycoprotein antibodies or verapamil, a pharmacological inhibitor of P-glycoprotein function. Clonogenic assays showed that P-glycoprotein confers long-term resistance to caspase-dependent apoptotic stimuli but not to caspase-independent cell death stimuli. This study has confirmed a potential novel physiological function for P-glycoprotein and it now remains to dissect the molecular mechanisms involved in the inhibition of capsase-dependent cell death by P-glycoprotein.
Internal ID Number: 9920858
URI: http://ahro.austin.org.au/austinjspui/handle/1/13643
URL: http://www.ncbi.nlm.nih.gov/pubmed/9920858
Type: Journal Article
Subjects: Antibodies, Monoclonal.pharmacology
Antigens, CD95.physiology
Antineoplastic Agents.pharmacology
Apoptosis.drug effects.physiology.radiation effects
Caspases.physiology
Cytotoxicity, Immunologic
DNA, Complementary.genetics
Dexamethasone.pharmacology
Enzyme Inhibitors.pharmacology
Etoposide.pharmacology
Fas Ligand Protein
Genes, MDR
Granzymes
Humans
Leukemia-Lymphoma, Adult T-Cell.pathology
Membrane Glycoproteins.pharmacology
Neoplasm Proteins.physiology
P-Glycoprotein.genetics.physiology
Perforin
Pore Forming Cytotoxic Proteins
Recombinant Proteins.pharmacology
Serine Endopeptidases.pharmacology
Transfection
Tumor Necrosis Factor-alpha.pharmacology
Tumor Stem Cell Assay
Ultraviolet Rays
Verapamil.pharmacology
Vinblastine.pharmacology
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.